EUVIMEDEUVIMED entdecken
Crossref

Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation

Yasutoshi Tatsumi, Tatsuya Masuda, Takayoshi Watanabe, Rohmad Yudi Utomo, Ummi Maryam Zulfin, Edy Meiyanto, Toshinori Ozaki, Yusuke Suenaga, Yasuhiko Kamikubo

Oncology Reports · 2025

DOI: 10.3892/or.2025.8880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Yasutoshi Tatsumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan. Hauptthemen laut MEDLINE: Osteosarcoma, Curcumin, Bone Neoplasms, Histones. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaCurcuminBone NeoplasmsHistonesE1A-Associated p300 Proteinp300-CBP Transcription FactorsAntineoplastic AgentsHumansAcetylationAnimalsCell ProliferationCell Line, TumorApoptosisChick EmbryoGene Expression Regulation, NeoplasticSTAT3 Transcription FactorMolecular Docking Simulation

Stichwörter der Autor:innen

CAMHATOSSTAT3curcumin analogsp300

Substanzen

CurcuminHistonesEP300 protein, humanE1A-Associated p300 Proteinp300-CBP Transcription FactorsAntineoplastic AgentsSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.
  • Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
  • Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.

Zitieren

APA

Tatsumi, Y., Masuda, T., Watanabe, T., Utomo, R. Y., Zulfin, U. M., Meiyanto, E., Ozaki, T., Suenaga, Y., & Kamikubo, Y. (2025). Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation. Oncology Reports. https://doi.org/10.3892/or.2025.8880

Vancouver

Tatsumi Y, Masuda T, Watanabe T, Utomo RY, Zulfin UM, Meiyanto E, et al. Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation. Oncology Reports. 2025. doi:10.3892/or.2025.8880

BibTeX
@article{Tatsumi2025,
  author = {Tatsumi, Yasutoshi and Masuda, Tatsuya and Watanabe, Takayoshi and Utomo, Rohmad Yudi and Zulfin, Ummi Maryam and Meiyanto, Edy and Ozaki, Toshinori and Suenaga, Yusuke and Kamikubo, Yasuhiko},
  title = {Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.8880}
}
Kostenlos starten →